Tag: DPCO
NPPA has fixed ceiling prices of 355 medicines & 882 formulations
National Pharmaceutical Pricing Authority (NPPA) fixes the ceiling prices of scheduled formulations as per provisions of DPCO, 2013 and monitors the prices of non-scheduled drugs so as to ensure that their prices do not increase beyond 10 percent in a year..................
MTaI welcomes NPPA move to cap trade margins of oxygen concentrators
Medical Technology Association of India has stated that the #NPPA's move to cap prices of oxygen concentrations will provide reasonable margin for players, while at the same time usher in affordability for patients.......................
NPPA’s green signal to bioresorbable stent by Meril Life Sciences for...
An extensively researched innovation, MeRes100 BRS is backed by 3-year efficacy and safety clinical trial data, has received 8 patents worldwide, CE mark approval and a DCGI granted 122E new drug approval that attests to its efficacy and safety for the indicated use.....................
India Pharma 2018 & India Medical Device 2018 held at Bengaluru
In his inaugural speech, the union minister for chemicals and fertilizers, Mr Ananthkumar urged the industry to take up the challenges of implementing Namo-Care in coordination with Make in India initiative of the government..............
MTaI welcomes govt’s move to restructure DPCO 2013
In a statement issued on May 10th, the Medical Technology Association of India (MTaI) has appreciated the union government's move to separate medical technology from the pharma industry........
MNC’s express disappointment over govt’s cornonary stent price cap order
The industry associations representing multinational medical device firms feel that the decision will stifle the innovation and push back global investors....
Coronary stent price cap order has no logic: Indian firms tell...
Association of Indian Medical Device Manufacturers (AIMeD) has also drawn attention to possible conflict and problem points which will arise now in the wake of this notification....